Vnitr Lek 2024, 70(3):E4-E9 | DOI: 10.36290/vnl.2024.040

Adverse obstetric and neonatal outcomes of pregnancy in high-risk women with heart disease

Juraj Dubrava1, Monika Kaldararova2, Zuzana Niznanska3, Miroslav Korbel3
1 Department of Cardiology, University Hospital Bratislava
2 Department of Cardiology, National Institute for Cardiovascular Diseases
3 1 Department of Gynecology and Obstetrics, University Hospital Bratislava

Background: The latest ESC guidelines on the management of cardiovascular diseases during pregnancy recommend estimating maternal cardiovascular risk according to the modified World Health Organization (mWHO) classification. In contrast, there are no validated models for predicting neonatal and obstetric risk in these women.

Objectives: To compare the neonatal and obstetric outcomes of pregnancy between two groups of mothers with heart disease: women at high to extremely high maternal risk (mWHO III-IV; group 1) and women at low to intermediate maternal risk (mWHO < III; group 2).

Methods: We included 48 consecutive women with clinically significant congenital heart diseases, valvular diseases, cardiomyopathies, aortic diseases, or heart rhythm disorders in a retrospective study. We assessed pregnancy outcomes in group 1 (19 pregnancies in 17 women, with 20 live-born neonates) and in group 2 (35 pregnancies in 31 women, with 34 live-born neonates).

Results: In group 1, there was a higher prevalence of newborns with low birth weight (50.0% vs 2.9%, p < 0.001), a lower prevalence of mature newborns (50.0% vs 94.1%, p < 0.01) and higher prevalence of preterm delivery (45.0% vs 5.9%, p < 0.01). Newborns of group 1 mothers had a significantly lower birth weight (2442±753 g vs 3285±457 g, p < 0.0001). Patients in group 1 gave birth significantly earlier than in group 2 (35.7±3.1 weeks vs 38.5±1.3 weeks, p < 0.00001). They had longer hospital stay (13.0±14.0 days vs 5.0±2.3 days, p < 0.001), higher prevalence of deliveries per Caesarean section (100% vs 63.6%, p < 0.01), and higher estimated blood loss during operative delivery (572±156 ml vs 474±111 ml, p < 0.05). We found a significantly higher risk of neonatal and obstetric complications of pregnancies in mWHO III-IV classes vs pregnancies in mWHO < III classes: delivery per Caesarean section (odds ratio [OR] 22.7, 95% confidence interval [CI] 1.3-409.0, p < 0.05), preterm delivery (OR 13.1, 95% CI 2.4-70.1, p < 0.01), low birth weight (OR 33.0, 95% CI 3.8-290.2, p < 0.01), neonatal immaturity (OR 16.0, 95% CI 3.0-85.5, p < 0.01).

Conclusion: Pregnancy in women at high to extremely high maternal risk (mWHO III-IV) was burdened with a high risk of neonatal and obstetric complications. We found significantly worse obstetric and neonatal outcomes in pregnancies in mWHO classes III-IV than in mWHO classes < III.

Keywords: heart disease, mWHO classification, neonatal outcomes, obstetric outcomes, pregnancy.

Accepted: April 29, 2024; Published: May 6, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dubrava J, Kaldararova M, Niznanska Z, Korbel M. Adverse obstetric and neonatal outcomes of pregnancy in high-risk women with heart disease. Vnitr Lek. 2024;70(3):E4-9. doi: 10.36290/vnl.2024.040.
Download citation

References

  1. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39(34):3165-41. Go to original source... Go to PubMed...
  2. Pieper P. Pregnancy risk assessment. In: Camm AJ, Lüscher TF, Maurer G, et al. The ESC Textbook of Cardiovascular Medicine (3 edn). Oxford University Press: Oxford 2018:2851. ISBN 9780198784906. Go to original source...
  3. Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848-55. Go to original source... Go to PubMed...
  4. Jastrow N, Meyer P, Khairy P, et al. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Cardiol. 2011;151(2):209-13. Go to original source... Go to PubMed...
  5. Toprak B, Govorov K, Kurz K, et al. Outcome of pregnancy in a contemporary cohort of adults with congenital heart disease- a 10-year, single-center experience. Cardiovasc Diagn Ther 2021;11(6):1344-55. Go to original source... Go to PubMed...
  6. Fernández-Campos BA, Vargas-Peñafiel J, Cruz-Dominguez MP, et al. Cardiac and obstetric outcomes in pregnant patients with heart disease: a retrospective cohort study. J Matern Fetal Neonatal Med. 2022;35(25):5140-5148. Go to original source... Go to PubMed...
  7. Suwanrath Ch, Thongphanang P, Pinjaroen S, et al. Validation of modified World Health Organization classification for pregnant women with heart disease in a tertiary care center in southern Thailand. Int J Womens Health. 2018:10:47-53. Go to original source... Go to PubMed...
  8. Roos-Hesselink JW, Ruys TPE, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657-65. Go to original source... Go to PubMed...
  9. Santacesaria S, Cataldo S, Annoni GA, et al. Pregnancy in women with cardiovascular disease in the guidelines era: an Italian single-center experience. J Cardiovasc Med (Hagerstown). 2016;17(10):750-5. Go to original source... Go to PubMed...
  10. van Hagen IM, Roos-Hesselink JW, Donvito V, et al. Incidence and predictors of obstetric and fetal complications in women with structural heart disease. Heart 2017;103(20):1610-18. Go to original source... Go to PubMed...
  11. Siu SC, Sermer M, Colman JM, et al. Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21. Go to original source... Go to PubMed...
  12. Drenthen W, Boersma E, Balci A, et al. ZAHARA Investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124-32. Go to original source... Go to PubMed...
  13. Kampman MA, Balci A, van Veldhuisen DJ, et al. ZAHARA II investigators. N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart.J 2014;35(11):708-15. Go to original source... Go to PubMed...
  14. Balci A, Sollie-Szarynska KM, van der Bijl AGL, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart 2014;100(17):1373-81. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.